Industry News 15 Oct 2026

InMed Pharmaceuticals (NASDAQ:INM) Major Shareholder Buys $10,667.93 in Stock

Source: The Lincolnian Online •By caroline horne •1 min read

InMed Pharmaceuticals Inc. (NASDAQ:INM – Get Free Report) major shareholder Adar1 Capital Management, Llc bought 8,021 shares of the business’s stock in a transaction dated Wednesday, October 14th. The stock was purchased at an average price of $1.33 per share, for a total transaction of $10,667.93. Following the acquisition, the insider directly owned 954,509 shares

This is a short summary. The full story is published by The Lincolnian Online.

Read full story at The Lincolnian Online
#corporate news#insider trades#pharmaceutical#stocks

Related news

Industry News
Torrent Pharma Profit Falls 9.6 Per Cent, Dr Reddy’s Slumps 36 Pc In Q2 FY27

Torrent Pharmaceuticals’ Q2 FY27 net profit fell 9.6% to Rs 534 crore, although revenue rose 50.8% to Rs 4,979 crore as expenses climbed 70.9%. Dr…

The Free Press Journal• 23 Oct 2026 •1 min read
#financial markets#fpj shorts#pharma
Read story
Industry News
Palleon Pharmaceuticals Presents Phase 2 Results for HLX79/E-602 in Primary Membranous Nephropathy at ASN Kidney Week…

Palleon Pharmaceuticals, a clinical-stage biotechnology company developing glycan editing therapeutics for autoimmune disease and cancer, today…

Financialcontent• 23 Oct 2026 •1 min read
#pharmaceutical#pharmaceuticals#phase 2
Read story
Industry News
Lupin appoints Brian Savage as President, Chief Legal Officer

He joins Lupin from Teva Pharmaceuticals, where he held several senior leadership roles since 2015, serving most recently as executive vice…

The Hindu - Business Line• 23 Oct 2026 •1 min read
#companies#pharmaceutical#pharmaceuticals
Read story
Industry News
Armando Rubio, Vicapsys CEO, on Pharmaceutical Supply Chain Resilience, U.S. Manufacturing and Expanding Acces...

As pharmaceutical supply chains become an increasingly important economic and national security priority, Vicapsys Life Sciences, Inc. is pursuing a…

Haute Living• 22 Oct 2026 •1 min read
#haute partners#pharmaceutical#supply chain and logistics
Read story
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Trending tags
#pharma #pharmaceutical #fda approval #diseases #pharmaceuticals #clinical trial #fda approves #pharma and healthcare #biosimilar #phase iii #science and innovations #research #vaccine #drug #world news
Browse by category
Industry News 89 Regulatory 5
Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit